ketotifen has been researched along with Inferior Dislocation in 1 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ademola, A | 1 |
| Hildebrand, KA | 1 |
| Schneider, PS | 1 |
| Mohtadi, NGH | 1 |
| White, NJ | 1 |
| Bosse, MJ | 1 |
| Garven, A | 1 |
| Walker, REA | 1 |
| Sajobi, TT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| PrEvention of Posttraumatic Joint contractuRes With Ketotifen 2[NCT03582176] | Phase 3 | 381 participants (Anticipated) | Interventional | 2019-04-26 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for ketotifen and Inferior Dislocation
| Article | Year |
|---|---|
PrEvention of posttraumatic contractuRes with Ketotifen 2 (PERK 2) - protocol for a multicenter randomized clinical trial.
Topics: Adolescent; Adult; Contracture; Double-Blind Method; Female; Fractures, Bone; Histamine H1 Antagonis | 2020 |